about
Rational design of oncocin derivatives with superior protease stabilities and antibacterial activities based on the high-resolution structure of the oncocin-DnaK complexA novel Hsp70 inhibitor prevents cell intoxication with the actin ADP-ribosylating Clostridium perfringens iota toxinHighly specific targeting and imaging of live cancer cells by using a peptide probe developed from rationally designed peptides.Novel peptide-protein assay for identification of antimicrobial peptides by fluorescence quenching.
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Rational design of novel peptidic DnaK ligands.
@ast
Rational design of novel peptidic DnaK ligands.
@en
type
label
Rational design of novel peptidic DnaK ligands.
@ast
Rational design of novel peptidic DnaK ligands.
@en
prefLabel
Rational design of novel peptidic DnaK ligands.
@ast
Rational design of novel peptidic DnaK ligands.
@en
P2093
P2860
P356
P1433
P1476
Rational design of novel peptidic DnaK ligands.
@en
P2093
Christian Lücke
Günther Jahreis
Katja Haupt
Markus Liebscher
P2860
P304
P356
10.1002/CBIC.201000166
P577
2010-08-01T00:00:00Z